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Abstract
Female Long–Evans rats sustained electrolytic lesions of the fimbria and the dorsal fornix causing a partial lesion of the septohippo-
campal pathway. Two weeks later, the rats received intra-hippocampal grafts of fetal septal cell suspensions. Nine to twelve months later,
the release of acetylcholine (ACh) in the hippocampus of sham-operated, lesion-only and grafted rats was measured by microdialysis. The
extent of cholinergic (re)innervation was determined by acetylcholinesterase (AChE) staining and densitometry. In both lesion-only and
grafted rats, the ratio of ACh release to AChE staining intensity was increased as compared to sham-operated rats, indicating a loss of
endogenous inhibitory mechanisms. Scopolamine (0.5 mg/kg i.p.), a muscarinic antagonist, increased ACh release in all treatment groups.
8-OH-DPAT (0.5 mg/kg s.c.), an agonist at serotonergic 5HT1A-receptors, induced an increase of hippocampal ACh release in sham-
operated rats. This effect was lost in lesion-only rats, but was fully restored by neuronal grafting. As 8-OH-DPAT influences hippocampal
ACh release by a postsynaptic action, this finding indicates that the host brain exerts a serotonergic influence on the grafted cholinergic
neurons. Ó 1997 Elsevier Science Ireland Ltd.
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The experimental lesion of the septohippocampal path-
way is an animal model for central cholinergic dysfunction
and Alzheimer’s disease and has been used repeatedly to
investigate functional effects of neuronal grafting. While
grafted neurons may establish new synaptic contacts in
the host brain and attenuate or even compensate for a variety
of lesion-induced neurophysiological and behavioral dys-
functions [14], the question of whether grafted neurons
show normal functional characteristics remains a great con-
cern. Using the microdialysis technique, Nilsson et al.
[11,12] have reported that basal forebrain grafts placed
into the denervated hippocampus were able to release acet-
ylcholine (ACh). An important finding was that this release
is to some extent under the control of host afferents; sensory
stimulation increased ACh release in sham-operated and
grafted rats, but not in lesion-only rats, and the same obser-
vation was made after electrical stimulation of the habenula.
Later it was reported that at least part of these host-derived
regulations of grafted cholinergic neurons involved cate-
cholaminergic fibres; thus, the ACh release in the grafted
hippocampus was raised after administration of amphet-
amine and apomorphine [8]. In a recent experiment using
brain slices [2], it was demonstrated that presynaptic
mechanisms involving muscarinic autoreceptors and
5HT1B heteroceptors were also functional on the axonal
terminals of grafted cholinergic neurons, thereby inhibiting
ACh release. In the present experiments, we have used the
microdialysis technique to test (1) if the muscarinic auto-
regulation characterized in vitro [2] also operates in vivo
and (2) if the grafted cholinergic neurons respond to the
activation of 5HT1A receptors with an increase of ACh
release.
Twelve female Long–Evans rats (R. Janvier, France),
91 – 1 days old, received an electrolytic lesion of the infra-
callosal component of the septo-hippocampal pathways
(fimbria-fornix) as described previously [4]. This lesioning
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procedure produces a partial lesion of the hippocampus as
shown by the loss of 50–70% of choline acetyltransferase
(ChAT) activity [2,5]. The electrode was placed at five sites
according to the following coordinates from Lambda: A
+5.2 mm, L – 0.8 mm, V - 3.3 mm; A +5.5 mm, L 0 mm,
V - 3.5 mm; A +5.8 mm, L – 1.8, V - 3.8 mm. Sham-oper-
ated rats (n = 6) were subjected to scalp incision and
removal of the bone overlying the dorsal parietal cortex.
Two weeks after lesion surgery, a subgroup of lesioned
rats (n = 6) received intra-hippocampal grafts of a cell sus-
pension prepared from the septal region of Long–Evans
fetuses (E 15) (for details, see [2]). The cell suspension
was injected into the dorsal hippocampus at the following
coordinates from Lambda: A +4.0 mm, L – 1.5 mm, V - 3.0
mm; A +3.0 mm, L – 2.5 mm, V - 3.3 mm (2 ml/site, 1 ml/
min). Another subgroup consisted of lesioned rats which did
not receive grafts (n = 6).
The in vivo release of ACh in the right dorsal hippocam-
pus was examined by microdialysis in sham-operated,
lesioned and grafted rats 9–12 months after transplantation.
Self-made, I-shaped microdialysis probes (exchange length,
1 mm; 240 mm o.d.) were implanted into the dorsal hippo-
campus. The probe was positioned according to the coordi-
nates from Lambda: A +2.5 mm, L - 0.3 mm, V - 3.8 mm
and, therefore, was positioned in about 1 mm posterior to
the most caudal graft. The experiments were carried out on
conscious rats 1 or 2 days after probe implantation. The
probe was perfused at 2 ml/min with artificial cerebrospinal
fluid (CSF; 147 mM NaCl, 4 mM KCl, 1.2 mM CaCl2 and
1.2 mM MgCl2) containing 10 mM neostigmine, and ACh
release was determined by high performance liquid chroma-
tography (HPLC) as detailed previously [6]. On day 1, basal
ACh release was determined; subsequently, 8-OH-DPAT
(0.5 mg/kg) was given by s.c. injection, and ACh release
was followed for 3–4 h (15 min samples). On day 2, the rats
received scopolamine (0.5 mg/kg i.p.). Subsequently, the
rats were transcardially perfused with phosphate-buffered
paraformaldehyde, and the fixated brains were cut into cor-
onal sections and stained for acetylcholinesterase (AChE)
[5]. The intensity of the AChE staining was quantified in the
right hippocampus using densitometry. For this purpose, the
brown AChE stain was transformed into grey scaling using
an EagleEye image analyzer, and the intensity of the grey
levels was quantified with the NIH Image software using
fixed frames to scan identical areas of the hippocampus. In
addition, the sections were used to verify the correct loca-
tion of the microdialysis probes, the survival of the grafts
and the lesion extents.
Fig. 1 compares the AChE staining intensities and the
basal ACh efflux observed in the three treatment groups.
The lesioning procedure led to a highly significant reduction
of AChE staining intensity in lesion-only rats which was
fully restored by grafting. The grafts also restored the orga-
notypic innervation pattern of the hippocampus as described
previously (data not shown; cf. [5]). Additional densito-
metric analyses showed that the fimbria-fornix lesions did
not affect the AChE-positivity in the neighboring cortical
and thalamic areas (data not shown). It was remarkable that,
after the partial lesioning procedure used in the present
study, the basal release of ACh in lesion-only rats was
only slightly and not significantly reduced (P . 0.1 vs.
sham-operated rats; Fig. 1). As AChE staining and choliner-
gic innervation are closely correlated [10], the high ACh
output in the partially lesioned hippocampus points to a
hyperactivity of remaining cholinergic fibres, because the
ratio of basal ACh release and AChE staining intensity was
clearly increased in lesion-only rats. Thus, surviving choli-
nergic fibres in a partially damaged septo-hippocampal
pathway maintained an increased basal transmitter output.
It should be noted, however, that the same animals were
unable to produce the high ACh output observed in sham-
operated rats under stimulated conditions (Fig. 2).
Our microdialysis data indicate that the remaining choli-
nergic fibres in the hippocampus of fimbria-fornix-lesioned
rats release significantly more ACh per time than those of
sham-operated rats. This interpretation is in agreement with
an earlier study of septo-hippocampal lesions in which par-
tial fimbrial lesions reduced the hippocampal ChAT activity
by 35% but did not result in a significant decrease of ACh
turnover in the hippocampus [7]. Compensatory increases of
ACh release have also been observed after aspirative lesions
of the septo-hippocampal pathway [9], but these changes
were measured 4 weeks after lesion surgery and were tran-
sient. We speculate that the lesion-induced hyperactivity of
cholinergic fibers observed in the present study was most
likely due to a lesion-induced destruction of (non-choliner-
gic) pathways which physiologically serve to modulate hip-
pocampal ACh release in intact animals. Likely candidates
for this modulatory function are GABAergic and serotoner-
gic fibres which are known to be damaged by fimbria-fornix
Fig. 1. AChE staining intensity (open bars) and basal ACh efflux (cross-
hatched bars) in the hippocampi of sham-operated (sham), lesion-only
(lesion) and grafted (graft) rats. Staining intensities were measured by
densitometry and ACh efflux by HPLC as described in the text. Data are
given as means – SEM. **P , 0.01 vs. sham (one-way ANOVA).
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lesions [13]. This reasoning is supported by the fact that, in
grafted rats, in which the AChE staining intensity was
restored to control values, the basal release of ACh was
significantly higher than in sham-operated rats (+57%;
P , 0.01 vs. sham-operated rats; Fig. 1). As the ratio
between the parameters ‘AChE staining intensity’ and
‘basal ACh release’ was similar in lesion-only and in grafted
rats (Fig. 1), grafted neurons apparently exhibit a hyperac-
tivity similar to the cholinergic fibres in the lesion-only
animals. In other words, the altered regulation of ACh
release in lesion-only animals was not restored after graft-
ing.
The effects of lesioning and grafting on ACh release were
further studied by pharmacological manipulations of trans-
mitter release. Scopolamine (0.5 mg/kg i.p.), by inhibiting
the autoreceptor on cholinergic terminals, induced an
immediate increase of ACh release in all treatment groups
which lasted for 2–3 h (Fig. 2). The clearcut increase of
evoked ACh release in lesion-only animals demonstrates
that the cholinergic fibres which remained after the FF
lesion are responsive to presynaptic modulation. However,
in lesion-only animals, the scopolamine-induced increases
of ACh release were much reduced, compared to sham-
operated animals. Thus, in lesion-only animals, the relative
increase of ACh release was 4-fold, compared to 8-fold in
sham-operated rats (Fig. 2). If expressed in absolute
amounts, lesion-only animals released a maximum of
146 – 23 fmol ACh/min while sham-operated animals
released 399 – 49 fmol ACh/min 30 min past scopolamine
injection. In grafted animals, the relative increase of evoked
ACh release was also smaller (5-fold; Fig. 2) than in sham-
operated rats. This observation is in agreement with a recent
study using brain slices in which a reduced sensitivity of
presynaptic muscarinic autoreceptor was reported in grafted
animals [2]. However, when ACh release is expressed in
absolute terms, maximum ACh output in grafted animals
(408 – 98 fmol ACh/min) was not significantly different
from sham-operated animals (399 – 49 fmol ACh/min),
and this finding underscores the functionality of muscarinic
autoreceptors in grafted tissue.
In addition to the response of grafted tissue to autorecep-
tor blockade, we were also interested in the effects of ser-
otonergic drugs on ACh release. The modulation of
serotonergic systems has repeatedly been shown to affect
cholinergic transmission and cognitive functions [1], and
previous experiments had shown that co-transplantation of
cholinergic and serotonergic tissue had more beneficial con-
sequences for the recovery of cognitive functions than either
graft alone [5]. For the present study, we chose to investi-
gate the effects of 8-OH-DPAT, a serotonergic agonist act-
ing specifically on 5-HT1A receptors. 8-OH-DPAT was
previously shown to enhance ACh release in cortex and
hippocampus of rats and guinea pigs (for review, see [1]).
It must be noted that systemic 8-OH-DPAT is known to
affect hippocampal ACh release via 5-HT1A receptors
which are located postsynaptically in the target regions of
the Raphe neurons. Thus, lesion studies indicated that hip-
pocampal 5-HT1A receptors are located postsynaptically on
Fig. 2. Increase of hippocampal ACh release after administration of sco-
polamine (0.5 mg/kg i.p.) at time 0 to sham-operated (sham), lesion-only
(lesion) and grafted (graft) rats. A control group of animals received saline
injections (0.5 ml i.p.; NaCl). ACh efflux is expressed as percentage of the
basal ACh release in each individual animal (the mean of values deter-
mined before drug administration was set at 100%). The data are given as
means – SEM of six experiments. Statistical analysis was done by two-
way ANOVA for repeated measurements, sham vs. lesion (F1,144 = 18.65;
P , 0.001); sham vs. graft (F1,144 = 13.16; P , 0.001); lesion vs. graft
(F1,144 = 0.33; P = 0.57).
Fig. 3. Effects of 8-OH-DPAT administration (0.5 mg/kg s.c.) on hippo-
campal ACh release in sham-operated ((A), sham), lesion-only ((B),
lesion) and grafted ((B), graft) rats. A control group of animals received
saline injections (0.5 ml s.c.) ((A), NaCl). ACh efflux is expressed as in
Fig. 2. The data are given as means – SEM of six experiments. Statistical
analysis was done by two-way ANOVA for repeated measurements, sham
vs. NaCl (F1,144 = 11.75; P , 0.001); graft vs. lesion (F1,144 = 17.24;
P , 0.001). Further statistical data are given in the text.
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non-cholinergic and non-serotonergic neurons [1], and in
microdialysis studies, the effect of 8-OH-DPAT on cortical
ACh output was found to be mediated by dopamine [3].
In the present study, 8-OH-DPAT, given systemically,
was found to significantly increase hippocampal ACh
release (Fig. 3A; P , 0.01 vs. saline). The effect was max-
imal after 30–60 min and lasted for approximately 2 h. It
should be noted that the injection of saline also leads to a
short-lasting increase of ACh release which is due to an
arousal reaction [11]. In lesion-only rats, 8-OH-DPAT did
not affect ACh release and, remarkably, the ACh increase
due to arousal was also absent (Fig. 3B). However, grafted
animals fully reacted to 8-OH-DPAT (Fig. 3B), and the
increase of ACh was not significantly different from the
response seen in sham-operated animals (Fig. 3A) (statisti-
cal comparison between the responses in sham-operated and
grafted rats: F1,144 = 0.74; P = 0.39 by two-way ANOVA
for repeated measurements). Thus, the grafted rats have
regained the ability to respond to 8-OH-DPAT administra-
tion with an increase of ACh release in the hippocampus. As
8-OH-DPAT affects ACh release by an indirect mechanism,
the most likely explanation for this finding is that the grafted
cholinergic neurons are sufficiently integrated into the neu-
ronal circuitry of the host brain to respond to drugs which
act in an indirect manner. In the present case, the grafted
cholinergic neurons seem to be under control of afferents
originating in the host brain and involving a serotonergic
mechanism. This conclusion complements earlier studies by
Nilsson et al. [11,12] who, using electrical and behavioral
stimulations, observed that septal cholinergic neurons
grafted into the denervated hippocampus are under control
of dopaminergic and/or noradrenergic afferents [8].
In conclusion, the present study demonstrates that septal
grafts lead to a restoration of ACh release in the hippocam-
pus of fimbria-fornix lesioned animals. However, the high
basal ACh efflux observed in grafted animals indicates a
hyperactivity of these fibres, an observation which is also
evident in the lesion-only animals and which may be due to
a loss of endogenous inhibitory control. We report that
grafted cholinergic neurons were sensitive to cholinergic
autoregulation, and we demonstrate, to our knowledge for
the first time, that the host brain exerts control on grafted
cholinergic neurons by a serotonergic mechanism involving
5-HT1A receptors, a type of control which is also found in
the septo-hippocampal system of intact rats.
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